BRÈVE publiée le 27/09/2024 à 18:45, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller’s
BRÈVE publiée le 27/09/2024 à 18:45, il y a 2 années 1 mois Fuller, Smith & Turner PLC : transaction sur actions propres Actions Propres Rachat D'actions Actions Ordinaires Bourse De Londres Fuller
COMMUNIQUÉ DE PRESSE publié le 27/09/2024 à 18:40, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of own 'A' ordinary shares as part of a share buyback program London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares
BRÈVE publiée le 26/09/2024 à 19:10, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in Own Shares Ordinary Shares Share Buyback Numis Securities Disclosure Rules Fuller’s
BRÈVE publiée le 26/09/2024 à 19:10, il y a 2 années 1 mois Fuller, Smith & Turner PLC : transaction sur actions propres Rachat D'actions Actions Ordinaires Numis Securities Fuller Règles De Divulgation
COMMUNIQUÉ DE PRESSE publié le 26/09/2024 à 19:05, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 'A' ordinary shares as part of its share buyback program, detailing prices and total voting rights Voting Rights London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC 'A' Ordinary Shares
BRÈVE publiée le 26/09/2024 à 16:31, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Director / PDMR Shareholding Update Corporate Governance Stock Market Share Transactions Fuller Smith & Turner Management Actions
BRÈVE publiée le 26/09/2024 à 16:31, il y a 2 années 1 mois Fuller, Smith & Turner PLC : Actualisation de l'actionnariat des administrateurs et de PDMR Gouvernance D'Entreprise Bourse Fuller Smith & Turner Transactions Sur Actions Mesures De Gestion
COMMUNIQUÉ DE PRESSE publié le 26/09/2024 à 16:26, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Director / PDMR Shareholding Fuller, Smith & Turner PLC notified of Director / PDMR Shareholding transactions. Details disclosed in accordance with EU Market Abuse Regulation PDMR Fuller, Smith & Turner PLC Shareholding Director EU Market Abuse Regulation
BRÈVE publiée le 25/09/2024 à 18:49, il y a 2 années 1 mois Fuller, Smith & Turner PLC: Transaction in Own Shares Voting Rights London Stock Exchange Share Buyback Market Abuse Regulation Financial Disclosure
Publié le 04/11/2026 à 18:00, il y a 8 heures 38 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 8 heures 38 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 8 heures 54 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 3 heures 28 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 3 heures 38 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 4 heures 23 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 4 heures 33 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 2 heures 35 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 6 heures 57 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 7 heures 13 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 7 heures 55 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 8 heures 33 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
